Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paediatric myelodysplasia

S J Passmore1, I M Hann

  • 1Department of Haematology and Oncology, Great Ormond Street Children's Hospital, London, UK.

British Medical Bulletin
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subdural haemorrhage as a predisposing factor for hyponatraemic convulsions in an infant undergoing test dose DDAVP infusion.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.

British journal of cancer·2005
Same author

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.

Leukemia·2005
Same author

MRC trials in childhood acute myeloid leukaemia.

Annals of hematology·2004
Same author

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.

Leukemia·2002
Same author

Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies.

British journal of cancer·2002
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Childhood myelodysplastic syndromes (MDS) are diverse. Bone marrow transplant (BMT) offers a cure for many, but some MDS types require tailored treatment. Prognosis improves with matched sibling BMT and unrelated donor BMT availability.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Stem Cell Transplantation

Background:

  • Childhood myelodysplastic syndromes (MDS) represent a varied group of pediatric hematologic disorders.
  • Many pediatric MDS cases exhibit resistance to conventional intensive chemotherapy regimens.
  • Bone marrow transplant (BMT) is currently the sole curative option for numerous pediatric MDS patients.

Purpose of the Study:

  • To highlight the heterogeneity within pediatric myelodysplastic syndromes.
  • To emphasize the necessity of differentiating indolent MDS types for appropriate treatment.
  • To discuss the evolving role and improving outcomes of BMT in treating childhood MDS.

Main Methods:

  • Review of existing literature on pediatric myelodysplastic syndromes.

Related Experiment Videos

  • Analysis of treatment responses and outcomes, particularly concerning chemotherapy and BMT.
  • Comparative assessment of matched sibling BMT versus unrelated donor BMT efficacy.

    • Main Results:

    • Pediatric MDS is not a monolithic entity; distinct subtypes exist with varying clinical courses.
    • Certain pediatric MDS subtypes follow a more indolent progression, necessitating individualized therapeutic strategies.
    • Outcomes for children undergoing matched sibling BMT for MDS are progressively improving.

    Conclusions:

    • Accurate classification of pediatric MDS subtypes is crucial for optimizing patient management.
    • Bone marrow transplant (BMT) is a vital curative treatment for childhood MDS, with expanding accessibility through unrelated donors.
    • Continued advancements in BMT techniques and donor availability are enhancing the long-term prognosis for pediatric MDS patients.